It scored not one, but two beats on analyst estimates for its third-quarter performance. This, despite a slight year-over-year decline in adjusted profitability. Revenue for Omnicell in its third ...
Results exceed previously issued second quarter 2025 guidance for revenues, non-GAAP EBITDA and non-GAAP EPS Raises full year 2025 total revenues, non-GAAP EBITDA and non-GAAP EPS guidance FORT WORTH, ...
The company continues to benefit from demand for its next-generation healthcare tech offerings. Revenue for Omnicell in its third quarter amounted to $311 million, notching the company a 10% gain in ...
Results exceed previously issued first quarter 2025 guidance for total revenues and non-GAAP EPS Updates full year 2025 non-GAAP EBITDA and non-GAAP EPS guidance FORT WORTH, Texas--(BUSINESS WIRE)-- ...
Hosted on MSN
Why Omnicell Stock Crushed the Market Today
It scored not one, but two beats on analyst estimates for its third-quarter performance. This, despite a slight year-over-year decline in adjusted profitability. 10 stocks we like better than Omnicell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback